Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 17654
Country/Region: Uganda
Year: 2016
Main Partner: Elizabeth Glaser Pediatric AIDS Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $15,293,346 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $2,340,285
Care: TB/HIV (HVTB) $567,312
Care: Pediatric Care and Support (PDCS) $1,115,905
Laboratory Infrastructure (HLAB) $1,400,700
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $1,970,867
Testing: HIV Testing and Counseling (HVCT) $1,130,032
Sexual Prevention: Other Sexual Prevention (HVOP) $570,590
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $883,256
Treatment: Adult Treatment (HTXS) $4,956,786
Treatment: Pediatric Treatment (PDTX) $357,613
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: <10 Female 2017 173
GEND_GBV Age/Sex: <10 Female 2017 294
GEND_GBV Age/Sex: <10 Male 2017 102
GEND_GBV Age/Sex: <10 Male 2017 171
GEND_GBV Age/Sex: 10-14 Female 2017 483
GEND_GBV Age/Sex: 10-14 Female 2017 822
GEND_GBV Age/Sex: 10-14 Male 2017 102
GEND_GBV Age/Sex: 10-14 Male 2017 171
GEND_GBV Age/Sex: 15-19 Female 2017 846
GEND_GBV Age/Sex: 15-19 Female 2017 1,471
GEND_GBV Age/Sex: 15-19 Male 2017 166
GEND_GBV Age/Sex: 15-19 male 2017 290
GEND_GBV Age/Sex: 20-24 Female 2017 845
GEND_GBV Age/Sex: 20-24 Female 2017 1,466
GEND_GBV Age/Sex: 20-24 Male 2017 173
GEND_GBV Age/Sex: 20-24 Male 2017 294
GEND_GBV Age/Sex: 25-49 Female 2017 343
GEND_GBV Age/Sex: 25-49 Female 2017 593
GEND_GBV Age/Sex: 25-49 Male 2017 173
GEND_GBV Age/Sex: 25-49 Male 2017 294
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 307
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 523
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 748
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 1,297
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 2,658
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 4,569
GEND_GBV Number of people receiving post-GBV care 2017 3,406
GEND_GBV Number of people receiving post-GBV care 2017 5,866
GEND_GBV Sum of Age/Sex Disaggregates 2017 860
GEND_GBV Sum of Age/Sex Disaggregates 2017 1,458
HTS_TST Age/sex: <1 2017 1,860
HTS_TST Age/sex: <1 2017 3,557
HTS_TST Age/sex: 1-9 2017 6,083
HTS_TST Age/sex: 1-9 2017 11,694
HTS_TST Age/sex: 10-14 Female 2017 5,233
HTS_TST Age/sex: 10-14 Female 2017 10,088
HTS_TST Age/sex: 10-14 Male 2017 5,244
HTS_TST Age/sex: 10-14 Male 2017 10,084
HTS_TST Age/sex: 15-19 Female 2017 25,038
HTS_TST Age/sex: 15-19 Female 2017 46,827
HTS_TST Age/sex: 15-19 Male 2017 22,453
HTS_TST Age/sex: 15-19 Male 2017 54,199
HTS_TST Age/sex: 20-24 Female 2017 37,570
HTS_TST Age/sex: 20-24 Female 2017 70,246
HTS_TST Age/sex: 20-24 Male 2017 33,686
HTS_TST Age/sex: 20-24 Male 2017 81,304
HTS_TST Age/sex: 25-49 Female 2017 57,599
HTS_TST Age/sex: 25-49 Female 2017 107,700
HTS_TST Age/sex: 25-49 Male 2017 51,649
HTS_TST Age/sex: 25-49 Male 2017 124,659
HTS_TST Age/sex: 50+ Female 2017 5,003
HTS_TST Age/sex: 50+ Female 2017 9,349
HTS_TST Age/sex: 50+ Male 2017 4,487
HTS_TST Age/sex: 50+ Male 2017 10,843
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 9,199
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 17,718
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 9,221
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 17,705
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 125,210
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 234,122
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 112,275
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 271,005
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 255,905
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 540,550
HTS_TST Service Delivery Point (Facility): Index testing 2017 11,804
HTS_TST Service Delivery Point (Facility): Index testing 2017 26,619
HTS_TST Service Delivery Point (Facility): Inpatient 2017 43,816
HTS_TST Service Delivery Point (Facility): Inpatient 2017 79,262
HTS_TST Service Delivery Point (Facility): Other PITC 2017 16,872
HTS_TST Service Delivery Point (Facility): Other PITC 2017 31,013
HTS_TST Service Delivery Point (Facility): Outpatient 2017 74,506
HTS_TST Service Delivery Point (Facility): Outpatient 2017 156,336
HTS_TST Service Delivery Point (Facility): Pediatric 2017 15,590
HTS_TST Service Delivery Point (Facility): Pediatric 2017 30,596
HTS_TST Service Delivery Point (Facility): PMTCT 2017 60,317
HTS_TST Service Delivery Point (Facility): PMTCT 2017 104,687
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 2,413
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 4,128
HTS_TST Service Delivery Point (Facility): VMMC 2017 30,587
HTS_TST Service Delivery Point (Facility): VMMC 2017 107,909
HTS_TST Sum of Age/Sex disaggregates 2017 247,962
HTS_TST Sum of Age/Sex disaggregates 2017 525,299
HTS_TST Sum of Aggregated Age/Sex <15 2017 18,420
HTS_TST Sum of Aggregated Age/Sex <15 2017 35,423
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 237,485
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 505,127
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 255,905
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 540,550
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 210
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 363
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 208
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 371
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 865
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 1,374
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 437
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 956
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 1,301
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 2,052
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 659
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 1,432
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 1,982
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 3,144
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 998
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 2,188
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 175
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 265
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 82
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 185
HTS_TST_POS Test Result by Age: Positive: <1 2017 57
HTS_TST_POS Test Result by Age: Positive: <1 2017 114
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 219
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 427
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 346
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 636
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 348
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 639
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 4,323
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 6,835
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 2,176
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 4,761
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 48
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 2,590
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 2,638
KP_PREV Total estimated number of key population in the catchment area 2017 5,148
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 4,632
KP_PREV_den By key population type: Men who have sex with men who are NOT sex workers (Denominator: Total estimated number of key population in the catchment area) 2017 157
KP_PREV_den By key population type: Men who have sex with men who are sex workers (Denominator: Total estimated number of key population in the catchment area 2017 359
PMTCT_ART Already on ART at beginning of current pregnancy 2017 1,991
PMTCT_ART Already on ART at beginning of current pregnancy 2017 3,350
PMTCT_ART New on ART 2017 1,428
PMTCT_ART New on ART 2017 2,408
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 104,512
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 60,675
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 2,254
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 3,810
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 612
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 1,051
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 14
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 37
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 111
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 191
PMTCT_EID Sum of Infant Age disaggregates 2017 2,866
PMTCT_EID Sum of Infant Age disaggregates 2017 4,861
PMTCT_STAT By: Known positives at entry 2017 1,942
PMTCT_STAT By: Known positives at entry 2017 3,339
PMTCT_STAT By: Number of new positives identified 2017 1,641
PMTCT_STAT By: Number of new positives identified 2017 2,737
PMTCT_STAT Number of new ANC and L&D clients 2017 62,220
PMTCT_STAT Number of new ANC and L&D clients 2017 107,193
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 60,675
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 104,512
PMTCT_STAT Sum of Positives Status disaggregates 2017 3,583
PMTCT_STAT Sum of Positives Status disaggregates 2017 6,076
PP_PREV Aggregated Age/sex: <15 Female 2017 1,673
PP_PREV Aggregated Age/sex: <15 Male 2017 1,539
PP_PREV Aggregated Age/sex: 15+ Female 2017 1,961
PP_PREV Aggregated Age/sex: 15+ Male 2017 1,973
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 7,146
PP_PREV Total number of people in the target population 2017 20,650
PrEP_NEW Female 15-19 2017 33
PrEP_NEW Female 15-19 2017 331
PrEP_NEW Female 20-24 2017 15
PrEP_NEW Female 20-24 2017 151
PrEP_NEW Female 25-49 2017 9
PrEP_NEW Female 25-49 2017 89
PrEP_NEW Female 50+ 2017 1
PrEP_NEW Female 50+ 2017 9
PrEP_NEW Male 15-19 2017 25
PrEP_NEW Male 15-19 2017 246
PrEP_NEW Male 20-24 2017 7
PrEP_NEW Male 20-24 2017 66
PrEP_NEW Male 25-49 2017 9
PrEP_NEW Male 25-49 2017 89
PrEP_NEW Male 50+ 2017 1
PrEP_NEW Male 50+ 2017 8
PrEP_NEW Number of adult women and adolecent girls newly enrolled on oral or topical PrEP 2017 100
PrEP_NEW Number of individuals who have received antiretroviral preexposure 2017 989
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 8
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 82
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 372
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 14
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 199
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 711
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 281
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 1,107
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 281
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 1,107
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 7,769
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 1,318
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 122
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 771
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 403
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 2,331
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 793
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 4,667
TB_SCREENDX Screen Result: Screened Positive for TB 2017 1,940
TB_SCREENDX Screen Results: Screened Positive for TB 2017 326
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 769
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 662
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 9,965
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 58,652
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 5,118
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 30,195
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 4,389
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 3,881
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 16,514
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 97,117
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 16
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 74
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 348
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,166
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 28
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 108
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 640
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 2,126
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 1,032
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 3,474
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 1,032
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 3,474
TX_CURR Age/Sex: <1 2017 310
TX_CURR Age/Sex: <1 2017 46
TX_CURR Age/Sex: <1-9 2017 1,997
TX_CURR Age/Sex: 1-9 2017 354
TX_CURR Age/Sex: 10-14 Female 2017 3,205
TX_CURR Age/Sex: 10-14 Female 2017 558
TX_CURR Age/Sex: 10-14 Male 2017 2,758
TX_CURR Age/Sex: 10-14 Male 2017 473
TX_CURR Age/Sex: 15-19 Female 2017 501
TX_CURR Age/Sex: 15-19 Female 2017 2,936
TX_CURR Age/Sex: 15-19 Male 2017 152
TX_CURR Age/Sex: 15-19 Male 2017 900
TX_CURR Age/Sex: 20-24 Female 2017 13,489
TX_CURR Age/Sex: 20-24 Female 2017 2,290
TX_CURR Age/Sex: 20-24 Male 2017 6,039
TX_CURR Age/Sex: 20-24 Male 2017 1,023
TX_CURR Age/Sex: 25-49 Female 2017 39,291
TX_CURR Age/Sex: 25-49 Female 2017 6,673
TX_CURR Age/Sex: 25-49 Male 2017 21,747
TX_CURR Age/Sex: 25-49 Male 2017 3,690
TX_CURR Age/Sex: 50+ Female 2017 2,936
TX_CURR Age/Sex: 50+ Female 2017 501
TX_CURR Age/Sex: 50+ Male 2017 1,509
TX_CURR Age/Sex: 50+ Male 2017 253
TX_CURR Aggregated Age/Sex: <15 Female 2017 4,389
TX_CURR Aggregated Age/Sex: <15 Female 2017 769
TX_CURR Aggregated Age/Sex: <15 Male 2017 662
TX_CURR Aggregated Age/Sex: <15 Male 2017 3,881
TX_CURR Aggregated Age/Sex: 15+ Female 2017 58,652
TX_CURR Aggregated Age/Sex: 15+ Female 2017 9,965
TX_CURR Aggregated Age/Sex: 15+ Male 2017 5,118
TX_CURR Aggregated Age/Sex: 15+ Male 2017 30,195
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 16,514
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 97,117
TX_CURR Sum of age/sex disaggregates 2017 3,836
TX_CURR Sum of Age/Sex disaggregations 2017 653
TX_CURR Sum of Aggregated Age/Sex <15 2017 8,270
TX_CURR Sum of Aggregated Age/Sex <15 2017 1,431
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 88,847
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 15,083
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 97,117
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 16,514
TX_NEW Aggregated Grouping by Age: <1 2017 4
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 199
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 625
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 151
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 536
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 3,599
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 10,805
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,844
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 5,560
TX_NEW By Age/Sex: <1 2017 36
TX_NEW By Age/Sex: 1-9 2017 76
TX_NEW By Age/Sex: 1-9 2017 277
TX_NEW By Age/Sex: 10-14 Female 2017 163
TX_NEW By Age/Sex: 10-14 Female 2017 471
TX_NEW By Age/Sex: 10-14 Male 2017 107
TX_NEW By Age/Sex: 10-14 Male 2017 377
TX_NEW By Age/Sex: 15-19 Female 2017 176
TX_NEW By Age/Sex: 15-19 Female 2017 536
TX_NEW By Age/Sex: 15-19 Male 2017 48
TX_NEW By Age/Sex: 15-19 Male 2017 162
TX_NEW By Age/Sex: 20-24 Female 2017 831
TX_NEW By Age/Sex: 20-24 Female 2017 2,486
TX_NEW By Age/Sex: 20-24 Male 2017 373
TX_NEW By Age/Sex: 20-24 Male 2017 1,108
TX_NEW By Age/Sex: 25-49 Female 2017 2,411
TX_NEW By Age/Sex: 25-49 Female 2017 7,244
TX_NEW By Age/Sex: 25-49 Male 2017 1,336
TX_NEW By Age/Sex: 25-49 Male 2017 4,001
TX_NEW By Age/Sex: 50+ Female 2017 181
TX_NEW By Age/Sex: 50+ Female 2017 539
TX_NEW By Age/Sex: 50+ Male 2017 87
TX_NEW By Age/Sex: 50+ Male 2017 289
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 5,793
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 17,526
TX_NEW Sum of Age/Sex disaggregates 2017 5,713
TX_NEW Sum of Age/Sex disaggregates 2017 17,213
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 5,793
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 17,526
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 13,210
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 77,697
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 11,897
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 69,932
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 552
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 3,158
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 478
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 2,791
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 7,177
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 42,214
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 3,690
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 21,769
TX_PVLS Numerator: Indication: Routine 2017 11,897
TX_PVLS Numerator: Indication: Routine 2017 69,932
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 622
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 3,518
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 536
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 3,107
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 7,967
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 46,909
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 4,085
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 24,163
TX_PVLS_den Denominator: Indication: Routine 2017 13,210
TX_PVLS_den Denominator: Indication: Routine 2017 77,697
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 10
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 32
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 127
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 68
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 216
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 68
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 213
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 51
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 186
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 67
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 200
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 260
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 850
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 34
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 757
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,472
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,732
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4,919
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 61
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 182
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 599
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,676
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 76
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 273
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 92
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 293
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,129
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,690
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,403
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 6,829
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 3,700
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 11,085
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 4,154
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 12,452
TX_RET_den Age/Sex: <1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 12
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 34
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 139
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 71
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 233
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 69
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 233
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 55
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 206
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 73
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 225
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 293
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 960
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 533
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,520
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 857
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,793
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,944
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5,519
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 74
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 210
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 150
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 402
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 79
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 296
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 96
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 321
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,279
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4,169
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,700
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 7,666
VMMC_CIRC By Age: 10-14 2017 54,013
VMMC_CIRC By Age: 15-19 2017 40,167
VMMC_CIRC By Age: 20-24 2017 19,390
VMMC_CIRC By Age: 25-29 2017 11,077
VMMC_CIRC By Age: 30-49 2017 11,077
VMMC_CIRC By Age: 50+ 2017 2,772
VMMC_CIRC By circumcision technique: Device-based VMMC 2017 150
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 138,346
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 138,496
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 138,496
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 116,342
Cross Cutting Budget Categories and Known Amounts Total: $876,032
Key Populations: Sex Workers $219,008
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Gender: Gender Based Violence (GBV) $438,016
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Key Populations: MSM and TG $219,008
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information